Nintedanib
PDF
OFEV® significantly reduces the risk of AE-IPF in the pooled INPULSIS®-1 and -2 and TOMORROW trials
PDF
Consistent treatment effect of OFEV® irrespective of disease stage at which it is initiated
3:05